INTRODUCTION {#SEC1}
============

Transposable elements (TEs) are DNA sequences that can move from one locus to another in the genome. TE induced genomic alterations, including insertions, deletions, duplications and translocations have been linked to changes in gene structure and expression ([@B1],[@B2]). TEs are found in virtually all eukaryotes where they can comprise the largest proportion of the genome. For example, sequences derived from TEs account for about half of the human genome and more than 70% of the genomes of some grass species ([@B3]).

TEs are classified by their transposition intermediate: class 1 TEs use RNA whereas the element itself is the transposition intermediate for class 2 TEs. Class 2 TEs are further classified into superfamilies on the basis of the element encoded transposase that catalyzes their movement ([@B4]). A TE family consists of transposase-encoding autonomous elements and non-autonomous elements that do not encode functional transposase. Within a family, elements usually share the terminal inverted repeat (TIR) sequence and the length of the target site duplication (TSD) that is generated upon insertion by the action of transposase ([@B5]).

*Mutator*--like transposable elements (MULEs) are class 2 TEs first identified in maize ([@B6],[@B7]) and subsequently found to be widespread with members in plants, animals, protozoans and fungi ([@B8]--[@B11]). Typical structural features of MULEs include long TIRs (\>100 bp) and 8--10 bp flanking TSDs ([@B12]). Non-autonomous MULEs often carry various sequences between their TIRs including host gene fragments; such elements are called Pack-MULEs ([@B13]). The high transposition frequency of one superfamily member, *MuDR*, has been widely exploited for gene tagging and mutagenesis in maize ([@B14]).

MULE transposases harbor a zinc finger DNA binding domain and a DDE catalytic domain ([@B15]--[@B17]). Phylogenetic analysis of transposases from all known eukaryotic superfamilies indicates that MULEs and *hATs* are closely related. For example they share a (C/D) ([@B2]) H motif located 15--45 amino acids downstream of the second D of the DDE triad and a W residue upstream of the E residue of the DDE triad ([@B18]). MULE and *hAT* elements also have longer TSDs than most other superfamilies, with the predominant TSD for *hAT* elements at 8 bp, and 8--10 bp for MULE elements ([@B19]). These shared features suggest that their transposition mechanisms may also be similar.

Among eukaryotic class 2 TEs, transposition begins with cleavage of one strand at both ends of the element, the nucleophile is usually H~2~O and this first cleavage results in exposed 3΄-hydroxyl groups (OH) at either the element end or the flanking (host DNA) end (Figure [1](#F1){ref-type="fig"}). The free 3΄OH serves as nucleophile for cleavage of the second strand and liberation of the transposon from the donor site ([@B20]). Three distinct mechanisms are known to date for second strand cleavage. As an example of the first pathway, Tc1*/mariner* transposases make double-strand cuts to release the transposon end from the donor site (Figure [1A](#F1){ref-type="fig"}) ([@B21],[@B22]). In the second pathway, first strand cleavage results in a 3΄OH in flanking DNA, which subsequently attacks the opposite strand to generate a hairpin structure (Figure [1B](#F1){ref-type="fig"}). This pathway is used by *hAT* and *Transib* elements in addition to the V(D)J recombinase RAG, which produces the highly diverse repertoire of T-cell receptors, antibodies and immunoglobulins ([@B23]--[@B25]). In the third pathway, employed by *piggyBac* elements ([@B26]), the 3΄OH generated in first strand cleavage at the transposon end attacks the opposite strand forming a hairpin structure at the transposon end (Figure [1C](#F1){ref-type="fig"}). After release from the donor site, the 3 ΄ OH at the free transposon ends serve as nucleophiles in a concerted attack on the target DNA in a reaction called strand transfer. Breaks in the target DNA are repaired by host enzymes, thereby generating the TSD flanking the inserted transposon. In contrast, breaks at the donor site are repaired either by end joining, a pathway that often leaves 'footprints' at the donor site reflecting element excision ([@B27],[@B28]) or homology-dependent gene conversion using a sister chromatid or homolog as template ([@B29]).

![Comparison of transposase-mediated cleavage and target joining mechanisms. Key steps in three DNA cleavage and target joining pathways of TE superfamilies. Black triangle represent the TIR. After transposon ends are released through different DNA cleavage mechanisms, the free 3΄ OH is used for target joining. (**A**) Tc1/mariner transposases make double-stranded cuts and generate element ends with free 3΄ OH. (**B**) hAT transposases catalyze the cleavage reaction through formation of a hairpin structure in flanking DNA. (**C**) piggyBac transposases generate a hairpin structure at the transposon end and release transposon from the donor site.](gkx357fig1){#F1}

Because MULEs and *hATs* have a close evolutionary relationship and share features including the (C/D) ([@B2])H motif, the W residue and long TSDs, it was hypothesized that they utilized similar mechanisms of transposition ([@B18]). To test this hypothesis, we studied transposition of the MULE *Muta1*, isolated from the genome of the mosquito, *Aedes aegypti*, which can spread dengue fever, yellow fever, chikungunya, zika and many other diseases ([@B30]--[@B32]). In a previous study we showed that *Muta1* transposase catalyzed the transposition of natural and artificial non-autonomous elements in a yeast assay ([@B33]). For this study, steps in the *Muta1* transposition mechanism were dissected, from the binding of purified transposase to *Muta1* ends, to cleavage of *Muta1* ends from the donor site, and finally, to the joining of cleaved *Muta1* ends to target DNA. Furthermore, mutagenesis analysis revealed that the conserved DDE triad and the W residue, shared by MULE and *hAT* transposases, plays critical roles in all steps of *Muta1* transposition. Finally, the terminal motif and subterminal repeats of the *Muta1* TIR also impact transposition reactions.

MATERIALS AND METHODS {#SEC2}
=====================

*Muta1* transposase expression and purification {#SEC2-1}
-----------------------------------------------

The 1512-bp *Muta1* transposase coding sequence was isolated by polymerase chain reaction (PCR) amplification from pMuta1-PAG415 ([Supplementary Figure S3A](#sup1){ref-type="supplementary-material"}) ([@B33]). In the PCR process, codons of 6 histidines were added to the N-terminal of the coding sequence and cloned between the NcoI and PstI sites of plasmid pBAD-Myc-HisC (Invitrogen) (which has a C-terminal His-tag) to generate pBAD-Muta1-His-NC. This fusion construct has 6 His residues on both the N and C termini of the *Muta1* coding sequence. *Escherichia coli* Top10 (Invitrogen) cells containing pBAD-Muta1-His-NC were grown with shaking at 30°C in LB medium containing 100 mg/ml carbenicillin to OD600 of 0.5. The culture was induced with 0.2% L-arabinose for 18 h at 16°C and cells were harvested by centrifugation at 8000 rpm for 5 min and resuspended in 8 ml of phosphate buffered saline buffer (50 mM NaH~2~PO~4~, 500 mM NaCl and 10 mM imidazole, pH 7.5). After addition of lysozyme (0.2 g/l of culture), cells were incubated on ice for 30 min before lysis by sonication for 30 min (Fisher Scientific). A total of 6 ml of lysate was loaded onto a pre-equilibrated column containing 1 ml Ni^2+^ resin (Invitrogen). The column was washed with 35 ml of Tris-buffered saline (TBS) buffer with 50 mM imidazole followed by 35 ml of TBS buffer with 100 mM imidazole. Muta1--His fusion protein was eluted with 7 ml of TBS buffer with 500 mM imidazole ([Supplementary Figure S1](#sup1){ref-type="supplementary-material"}), dialyzed twice against 35 ml volume of TBS buffer, concentrated using centrifuge filtration (Amicon system) to a final volume of 100 ul and glycerol added to a final concentration of 15% (v/v) for storage at −80°C.

DNA binding assay {#SEC2-2}
-----------------

DNAs substrates ([Supplementary Table S1](#sup1){ref-type="supplementary-material"}) were 5΄ end radiolabeled on both strands with gamma-P^32^-ATP and T4 polynucleotide kinase (NEB). *Muta1* transposase (15 ng) and 2 nM radiolabeled DNA were incubated in 25 mM HEPES, 5% (v/v) glycerol, 0.01% bovine serum albumin (BSA) and 4 mM dithiothreitol (DTT) in the presence of a 100-fold molar excess of sheared herring sperm DNA at room temperature for 30 min. Unlabeled full length *Muta1* L-TIR DNA was used in 100 or 500 molar excess as competitor DNA. All products were resolved on 5% native acrylamide gels and gels were dried and exposed to X-ray film.

Double strand break and end joining reactions {#SEC2-3}
---------------------------------------------

The DSB assay was conducted as previously described ([@B23],[@B26]). *Muta1* transposase (15 ng) was incubated with 1.5 nM radiolabeled *Muta1* L-TIR or other end fragments in 25 mM HEPES (pH 8.0), 3 mM Tris (pH 8.0), 75 mM NaCl, 2 mM DTT, 10 mM MgCl~2~, 0.01% BSA, 5% glycerol and 10 nM pUC19 in a final volume of 20ul at 30°C for different time intervals. Reactions were stopped by incubation in 1% sodium dodecyl sulphate and 20 mM ethylenediaminetetraacetic acid for 30 min at 65°C and displayed on 5% native and denaturing (with 7 M urea) acrylamide gels.

Following published protocols ([@B23],[@B26]), 200 nM of *Muta1* transposase was incubated with 1.5 nM of radiolabeled *Muta1* L-TIR or other end fragments in 25 mM HEPES (pH 8.0), 3 mM Tris (pH 8.0), 75 mM NaCl, 2 mM DTT, 10 mM MgCl2, 0.01% BSA, 5% glycerol and 10 nM pUC19 in a final volume of 20 ul at 30°C for 30 min. Products were displayed on native or denaturing (with 50 mM NaOH) 1% agarose gels.

Mutagenesis of *Muta1* transposase {#SEC2-4}
----------------------------------

Site-directed mutagenesis was used to generate mutant versions of *Muta1* transposase. One pair of primers was used for each mutation site, and PBAD-Muta1-His-NC plasmid (described in first section of 'Materials and Methods' section) was used as template. PCR products were digested with *Dpn1* to remove template, and the resulting plasmid was sequenced to confirm that mutations occurred as expected.

Yeast transposition assay {#SEC2-5}
-------------------------

The yeast transposition assay using *Saccharomyces cerevisiae* strain DG2523 and the pWL89A vector was described previously ([@B33]). Plasmid pMuta1-PAG415 ([Supplementary Figure S3A](#sup1){ref-type="supplementary-material"}, ([@B33])) was used to express transposase. Mutant versions of *Muta1NA1* were generated by PCR (primers in [Supplementary Table S1](#sup1){ref-type="supplementary-material"}). All non-autonomous elements were inserted in the XhoI site of pWL89A ([Supplementary Figure S3A and B](#sup1){ref-type="supplementary-material"}) through homologous recombination in yeast as previously described ([@B33]). Transformation was performed using the Frozen-EZ Yeast Transformation kit (Zymo research). Transformants were grown in 5 ml liquid media of CSM-leu-ura with 2% dextrose. After growth to saturation (36 h), cells were washed twice with 5 ml H~2~O, resuspended in 0.5 ml H~2~O and plated onto CSM-his-leu-ade with 2% galactose. Colonies were counted after incubation at 30°C for 15 days and viable counts were made by plating 100 μl of a 1 × 10^5^ and 1 × 10^6^ dilution on YPD plates.

Colony PCR was performed on *ADE2* revertant colonies using primers ([Supplementary Table S1](#sup1){ref-type="supplementary-material"}) flanking the insertion sites and PCR products were gel extracted (Zymoclean Gel DNA Recovery Kit) and sequenced for footprint analysis.

RESULTS {#SEC3}
=======

*Muta1* transposase binds the transposon end {#SEC3-1}
--------------------------------------------

*Muta1* transposase harbors a N-terminal FLYWCH type zinc-finger domain and a C-terminal DDE catalytic domain (Figure [2A](#F2){ref-type="fig"}). The 504 amino acid transposase was cloned, expressed and purified from *E. coli* as a His-tagged derivative. Initially, a C-terminal His-tag was added, however, because the fusion protein had poor affinity for the nickel column, a N-terminal His-tag was also added, and the double His-tag fusion protein was used in all experiments (see 'Materials and Methods' section).

![*In vitro* analysis of DNA binding of *Muta1* transposase. (**A**) The 3198-bp *Muta1* encodes a 504 amino acid transposase with the predicted zinc finger and catalytic (DDE) domains shown. White boxes indicate exons and grey boxes indicate non-coding regions. Black arrowheads represent the TIR whose substructure is expanded below. In this and all subsequent figures open arrows represent the 10-bp terminal palindromic motif, and black arrows are the 12-bp subterminal tandem repeat ([Supplementary Figure S2](#sup1){ref-type="supplementary-material"}). (**B**) The 165-bp DNA substrate used in DNA binding assays is 5΄ radiolabeled on both strands (asterisk) and contains a 20-bp flanking DNA segment (white box) and the full length *Muta1* L-TIR. (**C**) *Muta1* tpase and DNA binding assay. Lane 1: negative control without tpase protein. Lanes 2--4: fastest migrating band present in all lanes is DNA substrate, slower migrating bands (\>300 bp) are nucleoprotein complexes. Competitor DNA is unlabeled DNA in (B) which was added in 100 (+) or 500 (++) molar excess. One hundred molar excess of non-specific DNA is added in all reactions.](gkx357fig2){#F2}

*Muta1* is 3198 bp, flanked by 8 or 9 bp TSDs and a 145-bp TIR comprised of a 10 bp imperfect palindromic terminal motif and 9 copies of a 12 bp subterminal tandem repeat separated by 3--4 bp linkers (Figure [2A](#F2){ref-type="fig"} & B and Figure S2). The *Muta1* L-TIR and R-TIR share high sequence identity (97%) with all sequence differences located in the linkers DNA between subterminal repeats. For this reason the L- and R-TIR were considered symmetric and only L-TIR was used in this study.

Before determining transposition reaction intermediates (Figure [1](#F1){ref-type="fig"}), we tested whether *Muta1* transposase (purified from *E. coli*) could bind to L-TIR. A 5΄ P^32^ radiolabeled 165 bp fragment containing the full length L-TIR and 20 bp of flanking sequence was used as substrate in DNA binding assays (Figure [2B](#F2){ref-type="fig"}). The result indicates that *Muta1* transposase binds to DNA fragments containing *Muta1* L-TIR in the presence of 100 molar excess of non-specific DNA. The binding is specific as addition of competitor DNA reduced the binding strength (Figure [2C](#F2){ref-type="fig"}, lanes 2--4). The many bands (ranging from 350 bp to \>700 bp) may represent binding of oligomeric transposase proteins (Figure [2C](#F2){ref-type="fig"}, lanes 2--4).

*Muta1* transposase catalyzes double strand breaks through a hairpin intermediate on the flanking DNA side {#SEC3-2}
----------------------------------------------------------------------------------------------------------

As shown in Figure [1](#F1){ref-type="fig"}, each of the characterized cleavage pathways produces distinct reaction intermediates that can be determined experimentally. For the donor cleavage assay, *Muta1* transposase was incubated with a 5΄ radiolabeled 188 bp fragment containing the full length *Muta1* L-TIR and 43 bp of flanking sequence (Figure [3A](#F3){ref-type="fig"}). The reaction products were examined on both native and denaturing polyacrylamide gels to detect formation of a hairpin intermediate. On a native gel, two cleavage products were observed: the 145 bp band derives from the *Muta1* L-TIR and the 43 bp band from flanking DNA (Figure [3B](#F3){ref-type="fig"}, lanes 5--8, diagram on right). Both fragments increase in amount with increased time of incubation (Figure [3B](#F3){ref-type="fig"}, lanes 5--8).

![*In vitro* analysis of *Muta1* double strand cleavage. (**A**) The 188-bp DNA substrate is 5΄ radiolabeled and contains full length *Muta1* L-TIR (145 bp) and a 43 bp flanking segment. The possible reaction outcomes of the three DNA cleavage pathways in Figure [1](#F1){ref-type="fig"} are shown. (**B**) Reaction products on a native polyacrylamide showing 43 and 145 bp *Muta1* L-TIR products (lanes 5--8). Diagram on right indicates the predicted structure and size of each band. (**C**) Reaction products on a denaturing polyacrylamide gel showing the 145 and 86 nt bands (lanes 4--8).](gkx357fig3){#F3}

On a denaturing gel, two reaction products were detected (Figure [3C](#F3){ref-type="fig"}, lanes 4--8). The size of the two products is consistent with the middle pathway in Figure [3A](#F3){ref-type="fig"}: the 145 nt band reflects the *Muta1* L-TIR, and the 86 nt band reflects a linearized DNA hairpin containing both strands of the flanking DNA (43 + 43 nt, Figure [3C](#F3){ref-type="fig"} diagram and lanes 4--8). The amount of both fragments increases with increased incubation (from 5 to 120 min, Figure [3C](#F3){ref-type="fig"}, lanes 4--8). These results indicate that *Muta1* donor cleavage involves formation of a hairpin structure in flanking DNA (Figure [3A](#F3){ref-type="fig"}, model 2).

*Muta1* transposase joins the transposon end to target DNA {#SEC3-3}
----------------------------------------------------------

Donor site cleavage of *Muta1* generates a free 3΄ OH of the L-TIR (Figure [3A](#F3){ref-type="fig"}, middle cleavage model), which could serve as a nucleophile in an end joining reaction. To test if *Muta1* transposase could join the *Muta1* L-TIR to target DNA, a 'pre-cleaved' L-TIR fragment, that is, with its 3΄ OH already exposed, was constructed to serve as substrate with the target as intact pUC19 plasmid (2.6 kb). The 5΄ radiolabeled substrate contains the full length L-TIR with 20 bp of *Muta1* internal sequence (Figure [4A](#F4){ref-type="fig"}).

![*In vitro* analysis of *Muta1* end joining with target DNA. (**A**) The 165-bp DNA substrate contains full length *Muta1* L-TIR with 20 bp of *Muta1* internal sequence. Two lines indicate the DNA double strands. On the bottom strand, the 5΄ P is radiolabeled and the 3΄ OH is exposed. (**B**) Reaction products on a native agarose gel reveal two bands at 4.1 and 2.8 kb, which reflect joining product SEJ (nicked circular plasmid formed by joining of one transposon end to one plasmid strand) and DEJ (linearized plasmid formed by concerted joining of two transposon ends to two plasmid strands), as indicated in the diagram on right. (**C**) Reaction products on a denaturing agarose gel, where only the 2.8 kb is seen, which reflects both DEJ and SEJ products.](gkx357fig4){#F4}

Labeled substrate and pUC19 plasmid were incubated with *Muta1* transposase and reaction products displayed on native and denaturing agarose gels (Figure [4A](#F4){ref-type="fig"} and [B](#F4){ref-type="fig"}). Two bands of 2.8 and 4.1 kb were observed on the native gel (Figure [4B](#F4){ref-type="fig"}, lanes 3--5). The 2.8 kb band reflects double-end join (DEJ), which is generated by concerted joining of L-TIR substrate to each strand of target DNA, thereby forming a linear, double-stranded DNA molecule (Figure [4B](#F4){ref-type="fig"} diagram). The 4.1 kb band reflects a slower migrating nicked circular plasmid, which is the product of single-end join (SEJ), generated by joining one L-TIR substrate to one strand of the target DNA. In SEJ product, one strand of pUC19 is cleaved by the joining of one L-TIR fragment and the other plasmid strand is intact (Figure [4B](#F4){ref-type="fig"} diagram). The amount of SEJ and DEJ products increase over time (from 20 to 120 min, Figure [4B](#F4){ref-type="fig"}, lanes 3--5). On a denaturing gel, only one product is observed, consistent with DEJ and the linearized SEJ products, as the double-stranded SEJ product is denatured (Figure [4C](#F4){ref-type="fig"}, lanes 3--5). These results indicate that *Muta1* transposase is able to join the *Muta1* L-TIR fragment to target DNA *in vitro*.

Subterminal repeats impact *Muta1* transposition reactions *in vitro* {#SEC3-4}
---------------------------------------------------------------------

We next turned our attention to the *cis* requirements for *Muta1* transposition beginning with the distinctive long TIRs. *Muta1* can be classified as a type 2 foldback element because its TIR is composed of subterminal tandem repeats capable of forming secondary structures (Figure [2A](#F2){ref-type="fig"}) ([@B34],[@B35]). Although foldback elements are abundant in animal and plant species in the MULE and *P* superfamilies ([@B11],[@B34]--[@B36]), the function of the subterminal repeats is largely unknown. For the experiments described above, DNA fragments containing the full length L-TIR (with nine copies of the subterminal repeat) served as substrate (Figures [2](#F2){ref-type="fig"}--[4](#F4){ref-type="fig"}). The function of subterminal repeats was tested by reducing repeat number in substrates used in DNA binding, donor site cleavage and end joining assays.

DNA binding with full length L-TIR resulted in multiple bands, which suggested binding of oligomeric transposase (Figure [2C](#F2){ref-type="fig"}). To test if the binding of multiple transposase proteins correlated with the presence of multiple copies of subterminal repeats, we generated a series of DNA fragments consisting of variable copies of the repeat and analyzed their binding activity (Figure [5](#F5){ref-type="fig"}). All six DNA substrates contained the same 20 bp flanking sequence but different sequences derived from *Muta1* L-TIR, corresponding to one copy of the subterminal repeat (Figure [5A](#F5){ref-type="fig"}, lanes 1 and 2), the terminal motif alone (lanes 3 and 4), the terminal motif plus one, two or three copies of the subterminal repeat (lanes 5--10), and the full length TIR (lanes 11 and 12). Although the substrates vary in size (Figure [5A](#F5){ref-type="fig"}, see the variation in the rapidly migrating bands in lanes 1--12), binding to transposase is specific as addition of competitor DNA reduced binding of labeled substrate (lanes 1, 2, 5--12). A single band of ∼350 bp was observed for substrates containing the terminal motif and zero or one copy of the subterminal repeat (lanes 1, 2, 5 and 6). In contrast, no binding was detected with substrate containing only the subterminal repeat and 20 bp of flanking DNA (lanes 3 and 4). Additional bands (\>350 bp) were detected with substrates containing two or more copies of the subterminal repeat (lanes 7--12). These results suggest that the *Muta1* transposase binds specifically to fragments containing the 10 bp terminal motif and 20 bp flanking DNA (lanes 1 and 2) but not to the fragment containing only one copy of the subterminal repeat and flanking DNA (lanes 3 and 4). Increasing the number of the subterminal repeats promotes binding and generates additional bands (lanes 1, 2, 5--12).

![*In vitro* analysis of the impact of the *Muta1* subterminal repeats on transposase binding, double strand break and end joining reactions. (**A**) DNA binding assay. Diagrams at the top are structures of DNA substrates, all contain 20-bp flanking DNA segment (open box), subterminal repeats and terminal motif. The unlabeled 165-bp DNA containing 20-bp flanking DNA and the full length *Muta1* L-TIR is added in 100 (+) molar excess as competitor DNA. Reaction products are resolved on a native polyacrylamide gel. Fast migrating bands are DNA substrates (30--165 bp). (**B**) Donor cleavage assay. Diagrams at the top are the structures of DNA substrates, diagrams at the bottom are predicted structures of cleavage products. Reaction products are resolved on a native polyacrylamide gel. (**C**) End joining assay. Diagrams at the top are the structures of DNA substrates, intact pUC19 plasmid is used as target DNA, reaction products are resolved on a native agarose gel.](gkx357fig5){#F5}

To investigate the *cis* requirements for the donor site cleavage reaction, three different DNA fragments containing 100 bp of flanking DNA and either or both the terminal motif and the subterminal repeat were used as substrate (Figure [5B](#F5){ref-type="fig"} diagram). On a native polyacrylamide gel, the cleavage product (100 nt) was only detected when the substrate contained both motifs (Figure [5B](#F5){ref-type="fig"}, lane 3 and bottom diagram) after 60 min incubation with transposase.

In the end joining assay, three different DNA fragments containing either one of the two motifs or both and 20 bp of *Muta1* internal sequence were used as substrates (Figure [5C](#F5){ref-type="fig"} diagram). On a native agarose gel, DEJ and SEJ products were only detected when the substrates contained the terminal motif, with or without the subterminal repeat. (Figure [5C](#F5){ref-type="fig"}, lanes 2 and 6).

Terminal palindromic motif impacts *Muta1* transposition reactions *in vitro* {#SEC3-5}
-----------------------------------------------------------------------------

The sequence of the terminal motif of the *Muta1* TIR, GGGTCTACCC, is an imperfect palindrome with the fifth and sixth nucleotides unpaired. To determine if the sequence and the palindromic pattern of this motif impacts transposition, mutations in the terminal motif were tested for DNA binding, donor site cleavage and target joining reactions. For DNA binding, fragments used as substrates all contained 20 bp of flanking sequence and one copy of the subterminal repeat, and mutant versions of the terminal motif (Figure [6A](#F6){ref-type="fig"} diagram). This substrate was chosen because it was sufficient to bind transposase but did not form multisubunit complexes (Figure [5A](#F5){ref-type="fig"}, lanes 5 and 6), thus simplifying the interpretation of results.

![*In vitro* analysis of the impact of the *Muta1* terminal palindromic motif on DNA binding, double strand break and end joining reactions. (**A**) DNA binding assay. Diagram shows the structure of the DNA substrate. Underlined letters indicate mutations in the terminal motif. Reactions products are resolved on a native polyacrylamide gel. The unlabeled 165-bp DNA containing 20-bp flanking DNA and the full length *Muta1* L-TIR is added in 100 (+) molar excess as competitor DNA. Fast migrating bands are the DNA substrates (∼50 bp). (**B**) Quantification of the DNA binding of substrates used in (A). Strength of binding was quantified with ImageJ software and repeated five times to generate the standard deviation. (**C**) Cleavage assay. Diagram shows the structure of DNA substrates and cleavage products. Sequences of substrates are shown; underlined letters indicate mutations in the terminal motif. Reactions products are resolved on a native polyacrylamide gel. (**D**) End joining assay. Diagram shows the structure of the DNA substrate. Underlined letters indicate mutations in the terminal motif. Intact pUC19 plasmid is used as target DNA and reaction products are resolved on a native agarose gel.](gkx357fig6){#F6}

Mutations introduced in the terminal motif were selected to disrupt or restore the palindromic pattern (Figure [6A](#F6){ref-type="fig"} and [B](#F6){ref-type="fig"}, underlined letters). For example, the first mutant has a G to C substitution of the first nucleotide (Figure [6A](#F6){ref-type="fig"}, lane 2) and the palindrome is restored in the second mutant by a C to A substitution of the tenth position (Figure [6A](#F6){ref-type="fig"}, lane 3). Quantitation of band strengths indicated that mutations in the terminal motif reduce binding activity. However, in each case, second-site mutations that restored the palindromic pattern increase binding (Figure [6A](#F6){ref-type="fig"}, lanes 3--12, Figure [6B](#F6){ref-type="fig"}). These data indicate that the palindromic pattern is important for transposase binding and that the weaker binding caused by single mutations has more impact when the mutation is closer to the end of the TIR.

For the donor site cleavage assay, all DNA substrates contain a 100-bp flanking segment, one copy of the subterminal repeat and the terminal motif with the mutations indicated as underlined (Figure [6C](#F6){ref-type="fig"}). Cleavage products (100 nt) were observed for all mutant substrates but reduced in amount compared with the wild-type terminal motif (Figure [6C](#F6){ref-type="fig"}, lanes 2--12). These data demonstrate that terminal mutations reduced cleavage activity, but that cleavage did not always correlate with binding because mutations that restored the palindromic pattern did not increase cleavage.

For the end joining assay, substrates contain one copy of the subterminal repeat and the terminal repeat with the mutations indicated as underlined (Figure [6D](#F6){ref-type="fig"}). Based on the amount of SEJ and DEJ products, mutations in the third and fourth/fifth nucleotide (Figure [6D](#F6){ref-type="fig"}, lanes 7 and 12) have a more negative impact on end joining activity than mutations in other positions. Further, restoration of the palindromic pattern does not restore end joining activity (Figure [6D](#F6){ref-type="fig"}, lanes 2--12).

Identification of the catalytic core of the *Muta1* transposase {#SEC3-6}
---------------------------------------------------------------

Prior mutagenesis analysis identified several functionally important residues of the *Muta1* transposase including the DDE triad (D214, D283, E419) and W401 shared by transposases from the MULE and *hAT* superfamilies ([@B18], [@B33]). To probe the function, if any, of these amino acids in *Muta1* transposition, transposases with D214A, D283A, E419A, W401A or W401F mutations were purified and assayed for DNA binding, donor site cleavage and end joining activities.

Although still capable of binding specifically to the *Muta1* L-TIR fragment (Figure [7A](#F7){ref-type="fig"}, lanes 2--13), the alanine substitution mutant transposases lost activity in all DNA cleavage and joining reactions, while the W401F mutation retained partial activity. First, in the cleavage assay, no cleavage products were detected after 120 min incubation with alanine substitution mutant transposases (Figure [7B](#F7){ref-type="fig"}, lanes 3--6), and the W401F mutant generated less cleavage products than wild-type transposase (Figure [7B](#F7){ref-type="fig"}, lanes 2 and 7). The alanine substitution mutants were also defective in the end joining reaction (Figure [7C](#F7){ref-type="fig"}, lanes 3--6), as no joining products were detected, while the W401F mutation only retained partial activity (Figure [7C](#F7){ref-type="fig"}, lanes 2 and 7). These results indicate that the DDE triad and the W residue are involved in donor site cleavage and end joining of *Muta*1-mediated transposition.

![*In vitro* mutagenesis analysis of the role of conserved residues of *Muta1* transposase in transposition. (**A**) DNA binding assay using wild-type and mutant transposases. Diagram shows the structure of the DNA substrate. The unlabeled 165-bp DNA containing 20-bp flanking DNA and the full length *Muta1* L-TIR is added in 100 (+) molar excess as competitor DNA. Binding products are resolved on a native polyacrylamide gel. (**B**) Cleavage assay using wild-type and mutant transposases. Diagram shows the structure of DNA substrates and predicted cleavage product. Reaction products are resolved on a native polyacrylamide gel. (**C**) End joining assay using wild-type and mutant transposases. Intact pUC19 plasmid is used as target DNA. Reaction products are resolved on a native agarose gel.](gkx357fig7){#F7}

Prior studies showed that the conserved DDE triad of many transposases (*hAT* Tc1/*mariner, piggyback*) and the RAG1 recombinase were organized in an RNaseH-like fold to form the active site ([@B20],[@B37]--[@B41]). In the typical RNase H-like fold of β1-β2-β3-α1-β4-α2/3-β5-α4-α5/6, the DDE triad is usually located on specific secondary structures, with the first D on β1, the second D right after β4 and the E on α4 ([Supplementary Figure S4](#sup1){ref-type="supplementary-material"}, RAG1, ([@B20])). However, the secondary structure of most *A. aegypti* MULE transposases differ from the typical RNase H-like fold, because of the lack of β-strand adjacent to the second D of the DDE triad and the addition of four α-helices between the second D and the E ([Supplementary Figure S4](#sup1){ref-type="supplementary-material"}). These differences may be explained by the limitation of the secondary structure prediction programs, alternatively, the secondary structure predictions suggests the DDE triad may be brought together to form the active center through a non-standard RNase-H like fold, or through formation of oligomer.

Subterminal repeats and terminal motif impact *Muta1* transposition in yeast {#SEC3-7}
----------------------------------------------------------------------------

Yeast transposition assays were performed to determine if the *in vitro* results presented above correlate with changes in transposition frequency. The assay employs a *Muta1* transposase expression vector and a reporter vector containing a non-autonomous element inserted in the 5΄ UTR that blocks expression of the *ADE2* gene ([Supplementary Figure S3A](#sup1){ref-type="supplementary-material"}). Transposase-mediated element excision restores *ADE2* expression and permits cells to grow on minimal plates ([Supplementary Figure S3B](#sup1){ref-type="supplementary-material"}).

To assess the contribution, if any, of the number of subterminal repeats on the frequency of excision in yeast ([@B33]), we constructed a series of non-autonomous elements with different termini. Elements were generated by modifying *Muta1NA1*, a natural non-autonomous derivative of *Muta1* isolated from the *A. aegypti* genome and shown previously to transpose in yeast (Figure [8A](#F8){ref-type="fig"}, ([@B33])). The ends of *Muta1NA1* are not symmetric, containing three and seven copies of the subterminal repeat. Constructs were generated that contain the 315 bp internal sequence of *Muta1NA1* flanked by variable numbers of the two motifs, as indicated by the number of 'Ts' ([T]{.ul}erminal motif) and 'Rs' (subterminal [R]{.ul}epeat). For example, 1T0R+1T7R represents an element with one copy of the terminal motif but no subterminal repeat at the left end and one copy of the terminal motif and seven copies of the subterminal repeat at the right end. Excision frequencies of the artificial elements indicate that having the terminal motif and one copy of the subterminal repeat at both ends is sufficient for transposition, and increasing the copy number of the subterminal repeat increases element excision (Figure [8B](#F8){ref-type="fig"}).

![Analysis of the impact of *Muta1* subterminal repeats and terminal motif on transposition in yeast. (**A**) *Muta1NA1* contains the 10-bp terminal motif at both ends; three and seven copies of the subterminal repeats on the left and right ends, respectively, and 315 bp of internal DNA sequence. (**B**) Excision frequencies of *Muta1NA1* derivative elements generated by altering the copy number of the two motifs at both ends of Muta1NA1. TIR composition of each element is shown at the bottom (see text for details). Six replicates were used for each. (**C**) Excision frequencies of mutant versions of *Muta1NA1*. Mutations were introduced at both ends of the terminal motif of *Muta1NA1*, as indicated by underlined letters. Six replicates were used for each.](gkx357fig8){#F8}

To assess the impact of mutations of the terminal motif on excision frequency in yeast, the terminal motifs at both ends of *Muta1NA1* were replaced with the mutations analyzed previously (Figure [6](#F6){ref-type="fig"}). When compared to the excision frequency of *Muta1NA1*, all mutant elements showed a reduction in excision frequency with no apparent increase in excision frequency when the palindromic pattern is restored (Figure [8C](#F8){ref-type="fig"}). Consistent with the *in vitro* results, mutations closer to the end of the terminal motif had a more severe reduction in excision frequency (Figure [8C](#F8){ref-type="fig"}).

DISCUSSION {#SEC4}
==========

Results of this study provide evidence that the *Muta1* transposase catalyzes a double strand break mechanism involving formation of a hairpin structure in the flanking DNA, thereby releasing the transposon from the donor site (Figures [1B](#F1){ref-type="fig"} and [3C](#F3){ref-type="fig"}). Similar mechanisms have been reported for *hAT* and *Transib* elements, the V(D)J recombinase RAG1 and a subset of retroviral integrases (Figure [1B](#F1){ref-type="fig"}) ([@B20],[@B38]--[@B41]). These findings support the close evolutionary relationship between MULEs and *hATs*, first revealed by phylogenetic analysis ([@B18]).

After transposon excision, repair of the donor site requires opening the hairpin structure. Experiments presented in this study suggest that this step is probably not performed by *Muta1* transposase because the hairpin product accumulates and cleaved hairpin is not detected as the reaction time is extended (Figure [3C](#F3){ref-type="fig"}). Similar findings were also reported for *Hermes, Transib* and RAG1 ([@B23]--[@B25]). The hairpin may be opened by host enzymes like Artemis, which open similar structures ([@B23],[@B42]). Subsequent joining of the opened hairpins for *hAT, Transib* and RAG1 reactions may be achieved by the non-homologous end joining pathway, which often leaves footprints at the donor site ([@B23]--[@B25]). *Muta1* may utilize a different gap repair mechanism because the majority of excision events (\>90%) observed in a yeast transposition assay were precise (the element was removed as well as a single copy of the TSD, ([@B33])). Interestingly, *Muta1* footprints were detected more frequently when TSDs do not flank the donor element ([@B33]), similar to another MULE (rice *Os3378* ([@B43]). The different footprint pattern suggests the gap repair mechanism of *Muta1* and other MULEs may be distinct from *hAT* elements. It was hypothesized that *Os3378* utilizes a transposase-independent replication slippage pathway for the donor site gap repair, which requires at least 8 bp of homologous DNA flanking the break point ([@B43]), this may explain the dependence of precise excision on the presence of donor site TSD.

Mutagenesis analysis confirms the importance of the DDE triad in *Muta1* transposition reactions (Figure [7](#F7){ref-type="fig"} A--C). Direct involvement of the DDE triad in DSB and end joining reactions has also been shown for *hAT, Transib* and *piggyBac* transposases and for the RAG1 recombinase ([@B23]--[@B26]). Although the spatial organization of *Muta1* transposase is not the typical RNaseH-like fold that characterizes the transposases of other superfamilies, the multiple critical residues including the DDE triad and the W may be closely positioned to form the active center through more complex folding or the formation of transposase oligomers.

One explanation for the fact that MULE, *hAT, Transib* and V(D)J reactions all form hairpin structures in flanking DNA is that besides the DDE triad, they share a few functionally important amino acids that are critical for hairpin formation ([@B18]). Crystallographic analysis and *in vitro* assays revealed that W318 in the *Hermes* transposase plays an important role in positioning flanking DNA, which ensures that the DSB occurs at the correct position during the excision reaction ([@B38]). Furthermore, crystallographic analysis revealed that mutation of the corresponding W893 of RAG1 could destabilize its structure ([@B39]). Although the transposase of *Transib* elements were not reported to contain this W, we identified the W from multiple alignment analysis ([Supplementary Figure S5](#sup1){ref-type="supplementary-material"}). For *Muta1*, alanine substitution of the W401A mutation abolished all DNA cleavage and joining reactions, while W401F reduced activity (Figure [7](#F7){ref-type="fig"} B and C) and decreased the ratio of precise excision in yeast from 90 to 50% ([@B33]), indicating that W401F mutation could lead to inaccurate *Muta1* excision. Collectively, our data suggests this W plays a critical role in *Muta1* transposition, possibly in hairpin formation, which is similar to its role in *hAT* elements ([@B38]).

Prior to this study the function of the subterminal repeats of foldback transposons was unclear ([@B34]--[@B36]). Several lines of evidence presented in this study indicate the importance of subterminal repeats for transposition of foldback elements. First, increasing the number of subterminal repeats strengthens *Muta1* transposase binding. The generation of additional bands suggests that the presence of multiple copies of subterminal repeats could enhance transposase binding (Figure [5A](#F5){ref-type="fig"}). Second, in the donor site cleavage assay, cleavage product was only detected when the substrate contained the subterminal repeat (Figure [5B](#F5){ref-type="fig"}). Finally, increasing the copy number of the subterminal repeat increased excision frequency in yeast (Figure [8B](#F8){ref-type="fig"}). Collectively, these data provide the first experimental evidence that subterminal repeats are critical for transposition of foldback elements.

Lastly, our date demonstrate that the palindromic pattern of the *Muta1* terminal motif (GGGTCTACCC) impacts transposase binding (Figure [6A](#F6){ref-type="fig"}--[D](#F6){ref-type="fig"}). Several restriction enzymes also bind to palindromic sequences ([@B44]). *Muta1* termini recognition may utilize a similar mechanism, where the terminal palindromic motif provides structural hints to identify the end of the element. Mutations in the *Muta1* terminal motif also reduced donor site cleavage activity and excision frequency in yeast, suggesting its sequence may be optimal for transposition. Similarly, mutagenesis of the end of the TIR of the maize *Ds* element greatly reduced excision activity ([@B27]).
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